Intervention with WhatsApp Messaging to Assess the Effect of Self-designed Messages and Standardized Messages in Adherence to Antiretroviral Treatment in Young People Living with HIV in a Hospital in Lima, Peru: Randomized Control Trial
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 131
- 试验地点
- 2
- 主要终点
- Change from Baseline in the Result of SMAQ Questionnaire Adjusted for the Effect of Covariables
研究概览
简要总结
The goal of this clinical trial is to learn which type of messages is more efficacious to improve adherence to medication in young people living with HIV. The main question is aims to answer is:
-Are messages designed by participants (self-designed) more efficacious than messages designed by health providers to improve adherence to antiretroviral treatment (HIV medications)?
Researchers will compare both types of messages to see if one is better than the other in helping participants take their medications.
Participants will:
- Receive either messages designed by themselves or by health providers for 4 months.
- Be able to chat with health providers at any time, with special focus regarding questions about their condition, medications and health services.
- Complete questionnaires via WhatsApp describing how they are taking their medications, and how often they forget to take them.
- Complete questionnaires via WhatsApp describing their opinion about receiving the messages and being able to chat with health providers.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Health Services Research
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 29 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •People living with HIV of age 18-29 at the moment of signing informed consent.
- •Being a patient of the study center's Infectious Diseases clinic or National HIV Program, between March 2024 and July
- •Ownership of a mobile phone that supports WhatsApp.
排除标准
- •Being pregnant at the moment of signing informed consent.
- •Being illiterate at the moment of signing informed consent.
- •Being blind at the moment of signing informed consent
结局指标
主要结局
Change from Baseline in the Result of SMAQ Questionnaire Adjusted for the Effect of Covariables
时间窗: Baseline, 16 weeks.
The SMAQ questionnaire evaluates medication adherence. It provides a dichotomic result of adherence (yes/no), and a semiquantitative estimate of adherence. Greater than 95% adherence is considered as adherent, and less than 95% as non-adherent.
次要结局
- ART adherence measured by SMAQ Questionnaire at 4, 8 and 12 weeks of intervention(4, 8 and 12 weeks of intervention)
- Loss to follow-up(From the start of delivery intervention until study completion)
- Metrics on the use of a bidirectional platform for intervention delivery(End of the intervention at 16 weeks.)
- Time of permanence in the study(Baseline until study completion (16 weeks).)
研究者
Jeffrey Freidenson
Principal Investigator
Universidad Peruana Cayetano Heredia